Home

Header

1. Study Introduction

3. Why did you choose the interventions you chose to study?

5. Are results relevant for all COVID patients, or only those with a BMI greater than 25?

7. Did your study's findings prove Ivermectin is simply not effective in reducing the severity of COVID?

2. Why did you pursue this study?

4. How will these findings be applied?

6. What is the potential impact of these findings in the research & clinical space for COVID-19 drug treatments?

8. Do these results suggest everyone should take metformin when testing positive for COVID?

9. How should the average person interpret these studies when it comes to COVID-19 drug treatments?

This research is funded by:

UMN Clinical Translational Science Institute

The Parsemus Foundation

The Rainwater Foundation

FastGrants

UnitedHealth Group Research and Development

We work 365 days/year but are short-staffed at times. We will make every effort to call or email you back the same day, but we may not be able to. Please visit combatcovid.hhs.gov if you have not heard from us.